Clinical Trial Update: Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis [Phase 1, Phase 2]

View source ↗

Summary

Abatacept was studied in adults with mild relapsing granulomatosis with polyangiitis (GPA) in Phase 1/2 trials; the study has completed and results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatosis with Polyangiitis

Drugs mentioned

• ORENCIA (ABATACEPT)

Snippet

Sponsor: University of Pennsylvania | Conditions: Wegener's Granulomatosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-11-26